TRPA1 and neurodegenerative disease: In patients with oropharyngeal dysphagia associated with aging, stroke, or neurodegenerative diseases, the latency to evoke a cortical response to pharyngeal electrical stimulation is reduced during the acute ingestion of TRPA1 agonists [82].